in Newswire December 14, 2017

Johnson & Johnson, Janssen Biotech Facing Another Class Action Over Remicade ‘Scheme’

by Corrado Rizzi

Last Updated on December 14, 2017

The Welfare Fund of Plumbers Local Union No. 200 v. Johnson & Johnson et al

Filed: December 7, 2017 § 2:17cv5481

J&J and Janssen Biotech face more allegations the companies operated an 'exclusionary, competition-killing scheme' to maintain market control.




Last Updated on December 14, 2017 — 10:12 AM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.